These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

658 related items for PubMed ID: 9216841

  • 41. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 42. Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines.
    Otto AM, Faderl M, Schönenberger H.
    Cancer Res; 1991 Jun 15; 51(12):3217-23. PubMed ID: 2039997
    [Abstract] [Full Text] [Related]

  • 43. Sensitivity of a Tier I screening battery compared to an in utero exposure for detecting the estrogen receptor agonist 17 beta-estradiol.
    O'Connor JC, Frame SR, Biegel LB, Cook JC, Davis LG.
    Toxicol Sci; 1998 Aug 15; 44(2):169-84. PubMed ID: 9742655
    [Abstract] [Full Text] [Related]

  • 44. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K.
    J Steroid Biochem; 1983 Jul 15; 19(1A):59-68. PubMed ID: 6887873
    [Abstract] [Full Text] [Related]

  • 45. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK, Sutherland RL.
    Mol Pharmacol; 1987 May 15; 31(5):541-51. PubMed ID: 3553893
    [Abstract] [Full Text] [Related]

  • 46. Hydroxylated polychlorinated biphenyl metabolites are anti-estrogenic in a stably transfected human breast adenocarcinoma (MCF7) cell line.
    Kramer VJ, Helferich WG, Bergman A, Klasson-Wehler E, Giesy JP.
    Toxicol Appl Pharmacol; 1997 Jun 15; 144(2):363-76. PubMed ID: 9194421
    [Abstract] [Full Text] [Related]

  • 47. Identification of covalent attachment site of antiestrogenic estradiol 11 beta-derivatives on human estrogen receptor alpha ligand-binding domain.
    Aliau S, Mattras H, Borgna JL.
    J Steroid Biochem Mol Biol; 2006 Feb 15; 98(2-3):111-21. PubMed ID: 16439113
    [Abstract] [Full Text] [Related]

  • 48. Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: structure-activity studies.
    Dickerson R, Keller LH, Safe S.
    Toxicol Appl Pharmacol; 1995 Dec 15; 135(2):287-98. PubMed ID: 8545839
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. High concentrations of bisphenol A induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line.
    Chun TY, Gorski J.
    Toxicol Appl Pharmacol; 2000 Feb 01; 162(3):161-5. PubMed ID: 10652244
    [Abstract] [Full Text] [Related]

  • 52. [Selection of preparations with anticipated antiestrogen activity].
    Minina LS.
    Vopr Med Khim; 1979 Feb 01; 25(3):283-5. PubMed ID: 452493
    [Abstract] [Full Text] [Related]

  • 53. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E, Duchesne MJ, Semlali A, Fuentes M, Giamarchi C, Richard-Foy H, Nicolas JC, Pons M.
    Cancer Res; 2000 Aug 01; 60(15):4130-8. PubMed ID: 10945620
    [Abstract] [Full Text] [Related]

  • 54. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
    Duax WL, Swenson DC, Strong PD, Korach KS, McLachlan J, Metzler M.
    Mol Pharmacol; 1984 Nov 01; 26(3):520-5. PubMed ID: 6548545
    [Abstract] [Full Text] [Related]

  • 55. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y, Sato B, Noma K, Kishimoto S, Koizumi K, Aono T, Matsumoto K.
    Cancer Res; 1983 Sep 01; 43(9):4091-7. PubMed ID: 6871850
    [Abstract] [Full Text] [Related]

  • 56. Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro.
    Reddel RR, Murphy LC, Sutherland RL.
    Cancer Res; 1983 Oct 01; 43(10):4618-24. PubMed ID: 6883318
    [Abstract] [Full Text] [Related]

  • 57. Commonly occurring plant flavonoids have estrogenic activity.
    Miksicek RJ.
    Mol Pharmacol; 1993 Jul 01; 44(1):37-43. PubMed ID: 8341277
    [Abstract] [Full Text] [Related]

  • 58. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro.
    Connor K, Howell J, Chen I, Liu H, Berhane K, Sciarretta C, Safe S, Zacharewski T.
    Fundam Appl Toxicol; 1996 Mar 01; 30(1):93-101. PubMed ID: 8812239
    [Abstract] [Full Text] [Related]

  • 59. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P, Fortin S, Leblanc V, Parent S, Asselin É, Bérubé G.
    Steroids; 2012 Sep 01; 77(11):1113-22. PubMed ID: 22801351
    [Abstract] [Full Text] [Related]

  • 60. Estrogen-sensitive proliferation pattern of cloned Syrian hamster kidney tumor cells.
    Soto AM, Bass JC, Sonnenschein C.
    Cancer Res; 1988 Jul 01; 48(13):3676-80. PubMed ID: 3288332
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.